Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Goal directed fluid removal with furosemide in intensive care patients with fluid overload (GODIF)
2019-004292-40Phase 4Active
- Sponsor
- Nordsjællands Hospital Department of Anesthesia and Intensive Care Medicine
- Start
- Dec 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in hypervolemia and critical illness comparing Goal-directed furosemide with Placebo (2 arms). Primary endpoint: Days alive and out of hospital at day 90. Started Dec 2019; status: active.
02
Drugs
furosemide
03
Conditions
hypervolemiacritical illness
Beyond the preview
Go deeper on 2019-004292-40.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2019-004292-40.